CMMBVSLABT• 6 Months (Normalized)
CMMB vs LABT (Chemomab Therapeutics Ltd. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Apr 2 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMMB Performance $1.67
+7.05%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
LABT Performance $1.78
+%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin CMMB LEADS
+7.05 pts
CMMB outperforming by 7.05 percentage points
CMMBLABT
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMMB LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | CMMB Price | CMMB Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.67 | +7.05% | $- | - | |
| Sep 28, 2026 | $1.64 | +5.13% | $- | - | |
| Sep 25, 2026 | $2.16 | +38.46% | $- | - | |
| Sep 24, 2026 | $2.20 | +41.03% | $- | - | |
| Sep 23, 2026 | $2.28 | +46.15% | $1.78 | -97.94% | +144.09% |
| Sep 22, 2026 | $2.51 | +60.90% | $1.99 | -97.70% | +158.60% |
| Sep 21, 2026 | $2.48 | +58.97% | $2.05 | -97.63% | +156.60% |
| Sep 18, 2026 | $2.61 | +67.31% | $1.99 | -97.70% | +165.01% |
| Sep 17, 2026 | $2.80 | +79.49% | $1.86 | -97.85% | +177.34% |
| Sep 16, 2026 | $2.65 | +69.87% | $2.09 | -97.58% | +167.45% |
| Sep 15, 2026 | $2.47 | +58.33% | $2.17 | -97.49% | +155.82% |
| Sep 14, 2026 | $2.45 | +57.05% | $2.12 | -97.55% | +154.60% |
| Sep 11, 2026 | $2.58 | +65.38% | $2.22 | -97.43% | +162.81% |
| Sep 10, 2026 | $2.60 | +66.67% | $2.05 | -97.63% | +164.30% |
| Sep 09, 2026 | $2.69 | +72.44% | $2.32 | -97.32% | +169.76% |
Page 1 of 9